Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Vivimed Labs Debt & Borrowing

Vivimed Labs Ltd has informed the exchanges that it is outside the purview of the 'Large Corporate' framework as per SEBI circular criteria. This routine regulatory disclosure confirms the company's classification regarding debt issuance and borrowing obligations for the upcoming period.

Source

BSE filing, NSE: VIVIMEDLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Vivimed Labs Ltd: key numbers

Share price
₹5.64
Market cap
₹46.76 Cr
Revenue (annual)
₹69.99 Cr
Net profit (annual)
₹-176.5 Cr
P/E (TTM)
-0.3×Sector 46.1×
Promoter holding
7.57%-0.20% QoQ
FII holding
1.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Vivimed Labs Ltd

All →

Other debt & borrowing announcements

All →